GEORGE TOWN, CAYMAN ISLANDS — November 24, 2025 — Leads & Copy — Moolec Science SA (MLEC) is appealing Nasdaq’s determination that it does not meet the minimum $1.00 per share requirement, according to a press release issued November 21, 2025.
The Nasdaq Stock Market LLC issued a determination letter to Moolec on November 14, 2025, stating that the company’s ordinary shares had fallen below the $1.00 minimum for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The letter also stated the company would not be given the standard 180-day grace period to regain compliance.
Moolec has requested a hearing before a Nasdaq Hearings Panel, seeking a 180-day extension to present and implement a plan to regain compliance. This plan may include a reverse stock split, if deemed beneficial for shareholders.
The appeal automatically suspends the Nasdaq determination until the hearing on December 18, 2025. During this stay, Moolec’s shares will continue to trade on the Nasdaq Capital Market under the ticker symbol “MLEC” without interruption.
The company said it will monitor its share price and is dedicated to taking appropriate actions to resolve the deficiency and adhere to Nasdaq Listing Rule 5550(a)(2). Moolec stated the determination letter does not affect its business, operations, or reporting obligations to the Securities and Exchange Commission.
Moolec Science is focused on creating scalable protein solutions for the global food system by engineering plants and microbes. The company integrates Molecular Farming and precision fermentation to combine the cost efficiency of crops with the functionality and nutrition of animal proteins, offering sustainable and commercially viable ingredients. Moolec’s pipeline consists of alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture. The company has a strong intellectual property portfolio with over 118 granted and pending patents across several technology platforms. Moolec operates in the United States, Europe, and South America, and is working on a seed-to-ingredient strategy to transform food production. The company is listed on Nasdaq under the ticker MLEC.
Forward-looking statements in the press release are subject to risks and uncertainties, including changes in laws and regulations, economic and business factors, and the costs of scaling up Moolec’s business. The company is not obligated to update any forward-looking statements unless required by securities laws.
Press & Media:
comms@moolecscience.com
Investor Relations:
ir@moolecscience.com
Source: Moolec Science SA
